Smoking and inflammation: Their synergistic roles in chronic disease
Tóm tắt
Cigarette smoking is a major risk factor for the development and progression of cardiovascular and other chronic diseases. Cigarette smoke increases inflammatory mediators in the circulation and generates high amounts of reactive oxygen species, which are potent triggers of the inflammatory response and thought to play a central role in the development of atherosclerosis. Low-grade inflammation, atherogenic lipoprotein profile, and hypercoagulability are characteristic of smokers, and smoking cessation has been associated with a rapid improvement in the inflammatory balance. In individuals with high risk of coronary disease, 1 year of smoking cessation significantly counteracts impaired endothelial function, as assessed by a decreased plasma level of intercellular adhesion molecule. This review focuses on the connection between smoking and inflammation and their role in chronic disease.
Tài liệu tham khảo
Ambrose JA, Barua RS: The pathophysiology of cigarette smoking and cardiovascular disease: an update. J Am Coll Cardiol 2004, 43:1731–1737.
Howard G, Wagenknecht LE, Burke GL, et al.: Cigarette smoking and progression of atherosclerosis: The Atherosclerosis Risk in Communities (ARIC) Study. JAMA 1998, 279:119–124.
Kelly TN, Gu D, Chen J, et al.: Cigarette smoking and risk of stroke in the Chinese adult population. Stroke 2008, 39:1688–1693.
Tonstad S, Andrew Johnston J: Cardiovascular risks associated with smoking: a review for clinicians. Eur J Cardiovasc Prev Rehabil 2006, 13:507–514.
IARC Working Group on the Evaluation of Carcinogenic Risks to Humans: Tobacco smoke and involuntary smoking. IARC Monogr Eval Carcinog Risks Hum 2004, 83:1–1438.
Gritz ER, Vidrine DJ, Fingeret MC: Smoking cessation a critical component of medical management in chronic disease populations. Am J Prev Med 2007, 33:S414–S422.
Glantz SA, Parmley WW: Passive smoking and heart disease. Epidemiology, physiology, and biochemistry. Circulation 1991, 83:1–12.
Law MR, Hackshaw AK: A meta-analysis of cigarette smoking, bone mineral density and risk of hip fracture: recognition of a major effect. BMJ 1997, 315:841–846.
Orosz Z, Csiszar A, Labinskyy N, et al.: Cigarette smoke-induced proinflammatory alterations in the endothelial phenotype: role of NAD(P)H oxidase activation. Am J Physiol 2007, 292:H130–H139.
Barnoya J, Glantz SA: Cardiovascular effects of secondhand smoke: nearly as large as smoking. Circulation 2005, 111:2684–2698.
Pryor WA, Stone K: Oxidants in cigarette smoke. Radicals, hydrogen peroxide, peroxynitrate, and peroxynitrite. Ann N Y Acad Sci 1993, 686:12–27; discussion 27–28.
Stedman RL: The chemical composition of tobacco and tobacco smoke. Chem Rev 1968, 68:153–207.
Argacha JF, Adamopoulos D, Gujic M, et al.: Acute effects of passive smoking on peripheral vascular function. Hypertension 2008, 51:1506–1511.
Mishra NC, Rir-Sima-Ah J, Langley RJ, et al.: Nicotine primarily suppresses lung Th2 but not goblet cell and muscle cell responses to allergens. J Immunol 2008, 180:7655–7663.
Koshi R, Sugano N, Orii H, et al.: Microarray analysis of nicotine-induced changes in gene expression in a macrophage-like human cell line. J Period Res 2007, 42:518–526.
Kilaru S, Frangos SG, Chen AH, et al.: Nicotine: a review of its role in atherosclerosis. J Am Coll Surg 2001, 193:538–546.
Xiao D, Huang X, Lawrence J, et al.: Fetal and neonatal nicotine exposure differentially regulates vascular contractility in adult male and female offspring. J Pharmacol Exp Ther 2007, 320:654–661.
Lawrence J, Xiao D, Xue Q, et al.: Prenatal nicotine exposure increases heart susceptibility to ischemia/reperfusion injury in adult offspring. J Pharmacol Exp Ther 2008, 324:331–341.
Glass CK, Witztum JL: Atherosclerosis. The road ahead. Cell 2001, 104:503–516.
Bermudez EA, Rifai N, Buring JE, et al.: Relation between markers of systemic vascular inflammation and smoking in women. Am J Cardiol 2002, 89:1117–1119.
Henderson B, Csordas A, Backovic A, et al.: Cigarette smoke is an endothelial stressor and leads to cell cycle arrest. Atherosclerosis 2008 Feb 29 (Epub ahead of print).
Blankenberg S, Barbaux S, Tiret L: Adhesion molecules and atherosclerosis. Atherosclerosis 2003, 170:191–203.
Marz W, Scharnagl H, Winkler K, et al.: Low-density lipoprotein triglycerides associated with low-grade systemic inflammation, adhesion molecules, and angiographic coronary artery disease: the Ludwigshafen Risk and Cardiovascular Health study. Circulation 2004, 110:3068–3074.
Tonstad S, Sundfor T, Seljeflot I: Effect of lifestyle changes on atherogenic lipids and endothelial cell adhesion molecules in young adults with familial premature coronary heart disease. Am J Cardiol 2005, 95:1187–1191.
Halvorsen B, Lund Sagen E, Ueland T, et al.: Effect of smoking cessation on markers of inflammation and endothelial cell activation among individuals with high risk for cardiovascular disease. Scand J Clin Lab Invest 2007, 67:604–611.
Winkelmann BR, Boehm BO, Nauck M, et al.: Cigarette smoking is independently associated with markers of endothelial dysfunction and hyperinsulinaemia in nondiabetic individuals with coronary artery disease. Curr Med Res Opin 2001, 17:132–141.
Zang LY, Stone K, Pryor WA: Detection of free radicals in aqueous extracts of cigarette tar by electron spin resonance. Free Rad Biol Med 1995, 19:161–167.
Barua RS, Ambrose JA, Eales-Reynolds LJ, et al.: Dysfunctional endothelial nitric oxide biosynthesis in healthy smokers with impaired endothelium-dependent vasodilatation. Circulation 2001, 104:1905–1910.
Loscalzo J: Nitric oxide insufficiency, platelet activation, and arterial thrombosis. Circ Res 2001, 88:756–762.
Nedeljkovic ZS, Gokce N, Loscalzo J: Mechanisms of oxidative stress and vascular dysfunction. Postgrad Med J 2003, 79:195–199; quiz 198–200.
Casey RG, Joyce M, Roche-Nagle G, et al.: Young male smokers have altered platelets and endothelium that precedes atherosclerosis. J Surg Res 2004, 116:227–233.
Chavez J, Cano C, Souki A, et al.: Effect of cigarette smoking on the oxidant/antioxidant balance in healthy subjects. Am J Therap 2007, 14:189–193.
Schulze F, Lenzen H, Hanefeld C, et al.: Asymmetric dimethylarginine is an independent risk factor for coronary heart disease: results from the multicenter Coronary Artery Risk Determination Investigating the Influence of ADMA Concentration (CARDIAC) study. Am Heart J 2006, 152:493.e1–493.e8.
Rahman MM, Laher I: Structural and functional alteration of blood vessels caused by cigarette smoking: an overview of molecular mechanisms. Curr Vasc Pharmacol 2007, 5:276–292.
Yanbaeva DG, Dentener MA, Creutzberg EC, et al.: Systemic effects of smoking. Chest 2007, 131:1557–1566.
Hasnis E, Bar-Shai M, Burbea Z, Reznick AZ: Mechanisms underlying cigarette smoke-induced NF-kappaB activation in human lymphocytes: the role of reactive nitrogen species. J Physiol Pharmacol 2007, 58(Suppl 5):275–287.
Lambert C, McCue J, Portas M, et al.: Acrolein in cigarette smoke inhibits T-cell responses. J Allergy Clin Immunol 2005, 116:916–922.
Gajalakshmi V, Peto R, Kanaka TS, Jha P: Smoking and mortality from tuberculosis and other diseases in India: retrospective study of 43000 adult male deaths and 35000 controls. Lancet 2003, 362:507–515.
Klareskog L, Padyukov L, Alfredsson L: Smoking as a trigger for inflammatory rheumatic diseases. Curr Opin Rheumatol 2007, 19:49–54.
Yokode M, Kita T, Arai H, et al.: Cholesteryl ester accumulation in macrophages incubated with low density lipoprotein pretreated with cigarette smoke extract. Proc Nat Acad Sci U S A 1988, 85:2344–2348.
Pech-Amsellem MA, Myara I, Storogenko M, et al.: Enhanced modifications of low-density lipoproteins (LDL) by endothelial cells from smokers: a possible mechanism of smoking-related atherosclerosis. Cardiovasc Res 1996, 31:975–983.
Nishio E, Watanabe Y: Cigarette smoke extract inhibits plasma paraoxonase activity by modification of the enzyme’s free thiols. Biochem Biophys Res Commun 1997, 236:289–293.
Yamaguchi Y, Kagota S, Haginaka J, Kunitomo M: Evidence of modified LDL in the plasma of hypercholesterolemic WHHL rabbits injected with aqueous extracts of cigarette smoke. Environ Toxicol Pharmacol 2000, 8:255–260.
St-Laurent J, Boulet L, Bissonnette EY: Five days exposure to cigarette smoke extract alters bronchial epithelial cells mediator secretion [abstract 54]. J Allergy Clin Immunol 2008, S14.
Le Quément C, Guenon I, Gillon JY, et al.: The selective MMP-12 inhibitor, AS111793 reduces airway inflammation in mice exposed to cigarette smoke. Br J Pharmacol 2008 154:1206–1215.
Bakhru A, Erlinger TP: Smoking cessation and cardiovascular disease risk factors: results from the Third National Health and Nutrition Examination Survey. PLoS Med 2005, 2:e160.
Dobson AJ, Alexander HM, Heller RF, Lloyd DM: How soon after quitting smoking does risk of heart attack decline? J Clin Epidemiol 1991, 44:1247–1253.
Meade TW, Imeson J, Stirling Y: Effects of changes in smoking and other characteristics on clotting factors and the risk of ischaemic heart disease. Lancet 1987, 2:986–988.
Tracy RP, Lemaitre RN, Psaty BM, et al.: Relationship of C-reactive protein to risk of cardiovascular disease in the elderly. Results from the Cardiovascular Health Study and the Rural Health Promotion Project. Arterioscler Thromb Vasc Biol 1997, 17:1121–1127.